Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Immunome Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 114 | 2 | 115 | +3 |
| Shares | 47.8M | 3.77M | 51.6M | +7.60M (+17.3%) |
| Value | $578.4M | $45.6M | $754.7M | +$222.0M (+41.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Immunome Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 3,981,782 | $58.2M | 0.00% |
| Jefferies Financial Group Inc. | 1,875,892 | $27.4M | 0.45% |
| Hudson Bay Capital Management LP | 66,864 | $977.6K | 0.01% |
| Caption Management, LLC | 49,500 | $723.7K | 0.08% |
| Mariner, LLC | 34,739 | $507.9K | 0.00% |
| XTX Topco Ltd | 24,823 | $362.9K | 0.03% |
| CI Private Wealth, LLC | 24,234 | $354.3K | 0.00% |
| LPL Financial LLC | 17,450 | $255.1K | 0.00% |
| Intech Investment Management LLC | 14,987 | $219.1K | 0.00% |
| Engineers Gate Manager LP | 11,633 | $170.1K | 0.00% |
| Raymond James & Associates | 10,586 | $154.8K | 0.00% |
| Group One Trading, L.P. | 7,616 | $111.3K | 0.00% |
| Acadian Asset Management LLC | 3,237 | $47.0K | 0.00% |
| Simplex Trading, LLC | 1,326 | $19.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 353 | $5.16K | 0.00% |
| Nisa Investment Advisors, LLC | 199 | $2.91K | 0.00% |
| GAMMA Investing LLC | 129 | $1.89K | 0.00% |
| Northwestern Mutual Wealth Management Co | 100 | $1.46K | 0.00% |
| Signaturefd, LLC | 84 | $1.23K | 0.00% |
| Sterling Capital Management LLC | 53 | $775 | 0.00% |
| Russell Investments Group, Ltd. | 46 | $673 | 0.00% |
| National Bank of Canada | 1 | $15 | 0.00% |
Sold out (19)
Institutions that held Immunome Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Vestal Point Capital, LP | 1,000,000 | $12.1M |
| Balyasny Asset Management LLC | 375,242 | $4.54M |
| Jump Financial, LLC | 134,300 | $1.63M |
| Ensign Peak Advisors, Inc | 113,934 | $1.38M |
| Two Sigma Investments, LP | 107,846 | $1.30M |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 107,626 | $1.30M |
| Zimmer Partners, LP | 75,000 | $907.5K |
| Atika Capital Management LLC | 74,000 | $895.4K |
| Alpine Global Management, LLC | 51,178 | $619.3K |
| Vista Private Wealth Partners. LLC | 39,116 | $473.3K |
| J. Goldman & Co LP | 38,051 | $460.4K |
| Aquatic Capital Management LLC | 30,400 | $367.8K |
| Walleye Capital LLC | 25,457 | $308.0K |
| Voloridge Investment Management, LLC | 20,282 | $245.4K |
| EntryPoint Capital, LLC | 20,120 | $243.5K |
| Cubist Systematic Strategies, LLC | 19,421 | $235.0K |
| FNY Investment Advisers, LLC | 4,860 | $58.0K |
| Citadel Advisors LLC | 4,167 | $50.4K |
| Pacer Advisors, Inc. | 660 | $7.99K |
Not filed for Q3 2024 yet (2)
Institutions that held Immunome Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,758,864 | $45.5M |
| Emfo, LLC | 11,835 | $143.2K |